# Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy

> **NCT00256841** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Clinical Oncology Research Associates**

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** Chemotherapy
- **PROCEDURE:** Radiation Therapy

## Key facts

- **NCT ID:** NCT00256841
- **Lead sponsor:** Clinical Oncology Research Associates
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2014-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00256841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00256841, "Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00256841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*